Sutro presented updated data from the Phase 1b study of luvelta in combination with bevacizumab for patients with ovarian cancer in a poster presentation at the European Society for Medical Oncology ...

Recent Highlights In November 2024, Elicio presented a poster, “AMPLIFY-7P Phase 1a ... Provide updated RFS and OS data in an oral presentation at the 2024 ESMO Immuno-Oncology Congress, taking place ...

Pro forma cash and investment balance of $683.9 million as of September 30, 2024 expected to provide runway through 2027 across a number of impactful portfolio milestones. WATER ...

A copy of the ESMO poster can be found on the Publications page of Checkpoint's website. In November 2024, Checkpoint received $9.2 million in cash proceeds through the exercise of existing warrants.